Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $115.4500 (-0.87%) ($113.9100 - $116.7300) on Thu. Aug. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 42 | Latest Price | $115.4500(-0.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.9% a day on average for past five trading days. | Weekly Trend | LGND declines -2.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.52% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IYT(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $120.36 | 5 Day Moving Average | $117.22(-1.51%) | 10 Day Moving Average | $120.21(-3.96%) | 20 Day Moving Average | $120.36(-4.08%) | To recent high | -8.9% | To recent low | 22.7% | Market Cap | $1.855b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |